Discontinuation report INTRON A
Report ID | 92451 |
Drug Identification Number | 02238675 |
Brand name | INTRON A |
Common or Proper name | interferon alfa-2b solution for injection |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | INTERFERON ALFA-2B |
Strength(s) | 10000000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 1 x 10MIU |
ATC code | L03AB |
ATC description | IMMUNOSTIMULANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-04-12 |
Actual discontinuation date | 2021-04-12 |
Remaining supply date | 2021-04-09 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-08-26 | English | Compare |
v2 | 2019-08-26 | French | Compare |
v3 | 2021-03-02 | English | Compare |
v4 | 2021-03-02 | French | Compare |
v5 | 2021-04-09 | English | Compare |
v6 | 2021-04-12 | English | Compare |
v7 | 2021-04-13 | English | Compare |
Showing 1 to 7 of 7